Botulinum toxin A for the treatment of first bite syndrome
- PMID: 35935561
- PMCID: PMC9346218
- DOI: 10.21037/gs-22-359
Botulinum toxin A for the treatment of first bite syndrome
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-22-359/coif). The authors have no conflicts of interest to declare.
Comment on
- Gland Surg. 11:1251.
Similar articles
-
First bite syndrome: case report of 3 patients treated with botulinum toxin and review of other treatment modalities.Head Neck. 2013 Sep;35(9):E288-91. doi: 10.1002/hed.23150. Epub 2012 Sep 18. Head Neck. 2013. PMID: 22987482 Review.
-
Botulinum toxin A for the treatment of first bite syndrome-a systematic review.Gland Surg. 2022 Jul;11(7):1251-1263. doi: 10.21037/gs-22-112. Gland Surg. 2022. PMID: 35935568 Free PMC article. Review.
-
The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.Plast Reconstr Surg. 2007 Nov;120(6):1662-1666. doi: 10.1097/01.prs.0000282309.94147.22. Plast Reconstr Surg. 2007. PMID: 18040203
-
Novel treatment of first bite syndrome using botulinum toxin type A.Head Neck. 2009 Aug;31(8):989-93. doi: 10.1002/hed.21054. Head Neck. 2009. PMID: 19340864
-
Botulinum toxin as a therapeutic agent to prevent relapse in deep bite patients.J Craniomaxillofac Surg. 2016 May;44(5):584-9. doi: 10.1016/j.jcms.2016.01.021. Epub 2016 Feb 10. J Craniomaxillofac Surg. 2016. PMID: 27020772
References
Publication types
LinkOut - more resources
Full Text Sources